4.6 Article

Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

Cecile Pochon et al.

Summary: This study retrospectively analyzed the outcomes of children, adolescents, and young adults after their first allogeneic HSCT for AML, revealing age as an independent risk factor for NRM and extensive chronic GVHD. The study suggests that APA patients with AML could benefit from specific treatment regimens.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

Article Hematology

Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes

Rachel Phelan et al.

Summary: This report provides updated data and results on hematopoietic cell transplantation in the United States, with a focus on the use and outcomes in adolescent and young adult population. The report highlights differences in transplantation practices and outcomes between different age groups and disease types.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

Article Hematology

Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children

Christopher E. Dandoy et al.

Summary: This study compared transplant outcomes between myeloablative total body irradiation (TBI) containing and non-TBI regimens in children with de novo acute myeloid leukemia. The results showed that there was no difference in overall survival and leukemia-free survival between the two regimens, but TBI regimens had higher non-relapse mortality and lower relapse rates.

HAEMATOLOGICA (2021)

Review Oncology

Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors

Inken Hilgendorf et al.

Summary: Due to increasing cure rates, more children, adolescents, and young adults survive cancer, but they are at risk of long-term sequelae and require specific follow-up and treatment to prevent severe late effects.

ONCOLOGY RESEARCH AND TREATMENT (2021)

Review Hematology

Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend when and for whom in 2021?

Nico Gagelmann et al.

Summary: Allogeneic hematopoietic stem-cell transplantation is a potentially curative therapy for various hematologic diseases, with the success dependent on the conditioning regimen used pre-transplant. Studies have shown a correlation between conditioning regimen intensity and toxicity, prompting research to focus on reducing toxicity and increasing safety for broader populations. Individual factors and risks play a crucial role in selecting the appropriate intensity of the conditioning regimen.

HAEMATOLOGICA (2021)

Article Oncology

Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades A Blood or Marrow Transplant Survivor Study Report

Smita Bhatia et al.

Summary: This cohort study observed a decrease in late mortality among recipients of allogeneic BMT over the past 40 years, but life expectancy did not return to expected rates compared with the general US population. Furthermore, the reduction in risk of late mortality appeared to be more pronounced in those who underwent transplantation at a younger age or received bone marrow. Further efforts to mitigate recurrence of disease, infections, subsequent neoplasms, cardiovascular disease, and pulmonary disease may be beneficial for this population.

JAMA ONCOLOGY (2021)

Article Biophysics

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

C. Greil et al.

Summary: A study on 180 consecutive adult ALL patients undergoing allo-SCT found that achieving CR before transplantation and receiving TBI treatment were associated with better survival outcomes. There were no significant differences observed in survival between patients of different ages or phenotypes. Survival rates after allo-SCT have improved considerably over the last few decades.

BONE MARROW TRANSPLANTATION (2021)

Article Education, Scientific Disciplines

Cause-specific late mortality after allogeneic stem cell transplantation

Smita Bhatia

Hematology-American Society of Hematology Education Program (2019)

Review Oncology

Second Malignancies after Hematopoietic Stem Cell Transplantation

Ivetta Danylesko et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)

Article Hematology

Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults

Priti Tewari et al.

ACTA HAEMATOLOGICA (2014)

Article Hematology

Acute Myeloid Leukemia in Adolescents and Young Adults: Challenging Aspects

Yishai Ofran et al.

ACTA HAEMATOLOGICA (2014)

Article Biophysics

The EBMT activity survey: 1990-2010

J. R. Passweg et al.

BONE MARROW TRANSPLANTATION (2012)

Article Medicine, General & Internal

Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation

Eric J. Chow et al.

ANNALS OF INTERNAL MEDICINE (2011)

Review Hematology

Malignant hematologic diseases in adolescents and young adults

William A. Wood et al.

Article Oncology

Adolescent and Young Adult Oncology Training for Health Professionals: A Position Statement

Brandon Hayes-Lattin et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Medicine, General & Internal

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.

Ted A. Gooley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Hematology

Current role of stem cell transplantation in chronic myeloid leukaemia

Alois Gratwohl et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)

Article Hematology

Solid cancers after allogeneic hematopoietic cell transplantation

J. Douglas Rizzo et al.

Article Biophysics

Competing risk analysis using R: an easy guide for clinicians

L. Scrucca et al.

BONE MARROW TRANSPLANTATION (2007)